Equine wound care update highlights stage-based topical choices
New equine wound education emphasizes matching topical therapy to wound type, location, and healing stage.
Drug approvals, compounding updates, shortages, formulary changes, biologics.
53 stories
New equine wound education emphasizes matching topical therapy to wound type, location, and healing stage.
Experts warn that careless antiviral use in cats could threaten the drugs changing FIP outcomes.
FDA’s first generic omeprazole paste could improve access, but diagnosis and disease subtype still drive treatment.
A new HDYTT episode focuses on reversible sedation, analgesia, and local blocks for short canine and feline procedures.
New studies suggest both emetics work, but speed, adverse effects, and setting may shape which drug fits best.
Newer studies suggest apomorphine may act faster than ropinirole, despite similar overall emetic efficacy in dogs.
A new Clinician’s Brief podcast with Robin Downing highlights multimodal osteoarthritis pain management for companion animals.
Clinician’s Brief revisits osteoarthritis pain control as vets balance multimodal care, newer biologics, and closer safety monitoring.
New coverage highlights that equine gastric disease treatment depends on lesion type, confirmed diagnosis, and management change.
Equine pain guidance is emphasizing earlier assessment, multimodal analgesia, and closer monitoring.
New education and published guidance underscore that topical therapies in horses work best when matched to wound stage and sound wound management.
A new EVJ podcast spotlights equine antibiotic use as BEVA pushes practices to measure and justify prescribing.
Merck’s once-daily JAK inhibitor is now approved for dogs 6 months and older with pruritus linked to allergic dermatitis.
Merck’s Bravecto Quantum now has FDA approval for 12-month control of Asian longhorned and Gulf Coast ticks in dogs.
Fear Free says puppy vaccine visits should protect health and build confidence from the start.
New evidence suggests limb warming or insulation may help reduce heat loss in cats during surgery.
A new case series suggests remdesivir and GS-441524 can improve ocular FIP in most treated cats.
A new review says engineered live-attenuated VEEV vaccines may improve safety, stability, and protection.
A new review highlights live-attenuated VEEV vaccine candidates with stronger safety and protection data than TC-83.
A dvm360 podcast spotlights shock wave and PEMF options as multimodal pain care keeps expanding in veterinary medicine.
Elanco’s Trutect gives veterinarians a targeted parvo option, with full USDA approval and an added prevention label.
New RECOVER guidance updates CPR technique, monitoring, and drug use for dogs and cats.
Experts say spacing vaccines may help some small dogs, but reducing dose volume isn’t supported by evidence.
A new AJVR study found a 15-minute ice-pack application reduced skin perfusion in healthy dogs.
A resurfaced podcast spotlights Tasha McNerney’s push for stronger veterinary pain management and technician-led anesthesia education.
Elanco’s Trutect now has full USDA approval, adding momentum to targeted treatment and prevention strategies for canine parvovirus.
The 2024 RECOVER revision updates veterinary CPR drug use, ventilation, and code tools for dogs and cats.
A new petition could create board certification for pharmacists focused on animal health.
Point-of-care vaccine titers are gaining attention as a tool for more individualized vaccination decisions in dogs and cats.
A new AJVR study found feline and canine emodepside formulations are not bioequivalent in dogs.
A VETgirl podcast argues that sedation and pre-visit meds are part of compassionate care, not a clinical failure.
A new Clinician’s Brief podcast highlights practical, multimodal strategies for managing osteoarthritis pain in small animal patients.
A new review says rationally engineered live-attenuated VEEV vaccines may improve protection while addressing older safety concerns.
A new review says complete VEEV protection will likely require both antibody and T-cell responses.
A new review says redesigned live-attenuated VEEV vaccines may improve safety and complete protective immunity.
A new veterinary podcast episode highlights reversible sedation and local blocks for short procedures in dogs and cats.
A new study suggests veterinarians shouldn't treat feline topical and canine oral emodepside as interchangeable in dogs.
Elanco’s parvo monoclonal antibody now has full USDA approval, expanding a targeted option for treatment and post-exposure use.
Newer data suggest ropinirole works in dogs, but apomorphine may still be the faster, more reliable emetic in emergency cases.
New coverage and recent studies reinforce that equine gastric disease treatment depends on diagnosis, lesion type, and management change.
A new review says rationally engineered live-attenuated VEEV vaccines may improve safety and protection.
A new review says next-generation live-attenuated VEEV vaccines may overcome key safety and efficacy limits.
A new review says next-generation live-attenuated VEEV vaccines may improve safety, stability, and protective immunity.
Evidence continues to support quick, targeted sedation before stressful veterinary visits in dogs and cats.
Veterinary guidance increasingly supports early, tailored sedation for fearful or fractious dogs and cats.
A new JVIM case series suggests most cats with ocular FIP uveitis can respond well to antiviral therapy.
A new AJVR study found feline topical emodepside is not bioequivalent to a canine oral tablet in dogs.
Elanco’s parvo monoclonal antibody is reshaping care discussions with strong early survival and workflow signals.
Elanco’s canine parvovirus monoclonal antibody now has full USDA approval, with implications for treatment protocols and isolation time.
New comparative data suggest apomorphine may work faster and more reliably than ropinirole in emergency canine emesis.
Equine pain care is increasingly centered on repeated assessment, multimodal analgesia, and closer monitoring.
New discussion around ocular FIP highlights higher-dose antiviral strategies, legal U.S. access, and the need for close follow-up.
Elanco’s Trutect is now fully USDA approved, giving veterinarians a targeted option for treating canine parvovirus.